cbdMD (YCBD) risk factors

Item 1A of every cbdMD, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.

Open YCBD in Gloom →

cbdMD's chart, financials and news, free in your browser.Open YCBD in Gloom →

FY2025 10-K risk factors
28 risks1 new7 dropped7 reworded
The 2025 filing reflects a shift to Series B Preferred Stock replacing Series A.
Filed Dec 19, 2025
FY2024 10-K risk factors
34 risks
cbdMD faces severe going concern doubts after consecutive revenue declines and operating losses totaling $25.8 million over two years. The company struggles with NYSE American continued listing compliance and suspended dividends on its Series A Convertible Preferred Stock. Complex federal and state regulatory frameworks regarding hemp, CBD, and THC create ongoing legal, supply chain, and advertising uncertainties.
Filed Dec 18, 2024